Jianxiang Wang

Follow

Person

Tianjin, CN

People

Patents Grantslast 30 patents

Information Patent Grant
CD19-targeted chimeric antigen receptor and use thereof
- Patent number 11,547,728
- Issue date Jan 10, 2023
- JUVENTAS CELL THERAPY LTD.
- Jianxiang Wang
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Cloning of the human nuclear receptor co-repressor gene
- Patent number 6,949,624
- Issue date Sep 27, 2005
- The United States of America as represented by the Department of Health and H...
- Johnson M. Liu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
Chimeric Antigen Receptor Targeting CD22 and CD19 and Application t...
- Publication number 20230272069
- Publication date Aug 31, 2023
- Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medic...
- Jianxiang WANG
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CD19-TARGETED CHIMERIC ANTIGEN RECEPTOR AND USE THEREOF
- Publication number 20230201261
- Publication date Jun 29, 2023
- JUVENTAS CELL THERAPY LTD.
- Jianxiang WANG
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHOD FOR ARTERIAL ENDOTHELIAL-ENHANCED FUNCTIONAL T CELL GENERATION
- Publication number 20220396766
- Publication date Dec 15, 2022
- Institute of Hematology and Blood Diseases Hospital, CAMS & PUMC
- Tao CHENG
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
CD19-TARGETED CHIMERIC ANTIGEN RECEPTOR AND USE THEREOF
- Publication number 20220040234
- Publication date Feb 10, 2022
- JUVENTAS CELL THERAPY LTD.
- Jianxiang WANG
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...